Latest News
From the Journals
Cutavirus shows no association with primary cutaneous lymphoma
Biopsy analysis argues against pathogenic role for cutavirus in B- and T-cell disease.
Latest News
Medicare hospital deaths decline, hospice usage increases
During 2000-2015, Medicare recipients became less likely to die in hospitals.
News
Combo treatment under review for Waldenstrom macroglobulinemia
The FDA has granted priority review to the combination of ibrutinib plus rituximab.
Conference Coverage
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
AMSTERDAM –
From the Journals
PFS does not capture the benefit of PD-1 inhibitors
The protective effects of treatment were higher for OS than for PFS.
Conference Coverage
KEYNOTE-427: Pembrolizumab monotherapy shows promise in accRCC
CHICAGO – Pembrolizumab monotherapy shows promising efficacy and tolerability in treatment-naive patients with accRCC in the phase 2 KEYNOTE-427...
Conference Coverage
Hints of nivolumab efficacy seen in biliary tract cancers
BARCELONA – Five patients with intrahepatic cholangiocarcinomas or gallbladder tumors had partial but durable responses in a phase 2 trial.
Feature
Trump administration proposes changes to HHS, FDA
The action is part of a sweeping reform proposal, issued June 21, aimed at bringing more operational efficiency to the federal government as a...
From the Journals
Trump support high in counties with chronic opioid use
Policy to abate the opioid crisis must go beyond the medical model to incorporate socioenvironmental disadvantage factors and health behaviors.
From the Journals
Higher BMI tied to lower breast cancer risk in women before menopause
The effect was strongest in women aged 18-24 years, when it spanned breast cancer subtypes.
Commentary
Right to Try: Mission accomplished?
Dr. Jeffrey A. Zonder of the Barbara Ann Karmanos Cancer Institute explains why Right to Try falls short of expectations.